The content of this website was independently drafted and shaped by the Belgian Working Group of Heart Failure (BWGHF).
The BWGHF would like to thank and acknowledge our industry partners who helped support the BWGHF mission, scientific sessions and projects.
In 2021-2022, we launched the website with the support of Novartis, Pfizer, Bayer, Medtronic, Abbott, Servier, Daiichi-Sankyo, Roche, Vifor Pharma, AstraZeneca, Boehringer Ingelheim, Biotronik, Boston Scientific, Bristol Myers Squibb and Alnylam Pharmaceuticals.
Thanks to further annual support from Abbott, Novartis, Pfizer, Bayer, Roche, Vifor Pharma, Boehringer Ingelheim, Biotronik, AstraZeneca, Boston Scientific, Bristol Myers Squibb, Alnylam Pharmaceuticals and Novo Nordisk, we can keep the website up to date this year as well.
